Brenton Wynn
Pain Medicine · National City, CANPI 1528069820
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,037 of the $9,863 with a category attached, or 81.5%. It is spread thinly across 35 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,832 and has fallen 85.2% since, to $418 in 2025.
Across 468 payments — averaging $21.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Nevro Corp.$2K
- Scilex Pharmaceuticals Inc.$1K
- SPR Therapeutics, Inc$643
- Collegium Pharmaceutical, Inc.$642
- Avanir Pharmaceuticals, Inc.$402
- plus $3K from 29 others
What the payments were for
- Travel & lodging$1,72918%
- Food & beverage$8,03781%
- Education$971%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 63 | $1,750 |
| Nevro Corp. | 41 | $1,744 |
| Scilex Pharmaceuticals Inc. | 132 | $1,361 |
| SPR Therapeutics, Inc | 5 | $643 |
| Collegium Pharmaceutical, Inc. | 47 | $642 |
| Avanir Pharmaceuticals, Inc. | 17 | $402 |
| Amgen | 28 | $369 |
| Forte Bio-pharma LLC | 17 | $304 |
| Redhill Biopharma Inc. | 17 | $296 |
| Stimwave Technologies Incorporated | 8 | $294 |
| Daiichi Sankyo Inc. | 14 | $246 |
| Biohaven Pharmaceuticals, Inc. | 4 | $197 |
| AbbVie | 8 | $193 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $168 |
| Medtronic | 2 | $149 |
| Hikma Pharmaceuticals USA | 8 | $140 |
| Stryker | 3 | $134 |
| Sentynl Therapeutics, Inc. | 15 | $133 |
| Biodelivery Sciences International, Inc. | 9 | $124 |
| Curonix LLC | 2 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $64 |
| Shionogi Inc | 4 | $61 |
| GRT US Holding, Inc. | 1 | $60 |
| AstraZeneca | 3 | $55 |
| Kaleo, Inc. | 3 | $54 |
| Pfizer | 2 | $34 |
| Lilly USA, LLC | 1 | $25 |
| Si-bone, Inc. | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Bioventus LLC | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Boston Scientific | 1 | $17 |
| Vision Quest Industries Inc. | 1 | $15 |
| Pacira Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$883
- Senza Spinal Cord Stimulation System$644
- SPRINT PNS System$379
- NURTEC ODT$256
- NUEDEXTA$241
- Morphabond ER$125
- MOVANTIK$125
- VANTA ADAPTIVESTIM$120
- StimQ Receiver Stimulator Kit Channel A US w Receiver$110
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$110
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$110
- Freedom 4A Receiver Kit Channel A US w Receiver$110
- Freedom 8A Receiver Kit Channel A US w Receiver$110
- Proclaim IPG$110
- IVS - RF CANNULAE/NEEDLES$106
How this compares
$9,863 in reported general payments places this provider in the 80th percentile of 840 pain medicine providers in California.
Other pain medicine in National City
- Jason PopeSanta Rosa$2.1M
- Ramana NaiduLarkspur$1.4M
- Foead GeulaStudio City$1.3M
- Krishnan ChakravarthyTemecula$1.3M
- Kasra AmirdelfanWalnut Creek$783K
- Eric GrigsbyNapa$499K
- Jacqueline WeisbeinNapa$494K
- Gerald SacksSanta Monica$389K
- Samir ShethRoseville$356K
- Einar OttestadStanford$352K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.